Analyst Ratings for Xenon Pharmaceuticals (XENE)
XENE Rating Summary
XENE Price Target Summary
- Highest: $90.00 (Jefferies)
- Lowest: $46.00 (Deutsche Bank)
- Average: $70.93
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$70.93 (+111.8%)
* Over Last 12-Mos
Rating Score: 9.6 / 10
Percentile Rank: 91%
Avg. $ Target:
$70.93 (+111.8%)
* Over Last 12-Mos
Rating Score: 9.6 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/5/2026 | Guggenheim | Delma Caiati | New Coverage | Buy (N/A) |
73.00 (N/A) |
38.02 (33.49) |
-11.91% | Details |
| 9/18/2026 | Deutsche Bank | David Hoang | Downgrade | Hold (Buy) |
46.00 (90.00) |
56.76 (33.49) |
-41% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
